VELOXIS PHARMACEUTICALS A/S — Credit Rating and Financial Key Figures
CVR number: 26527767
Gdanskgade 18, 2150 Nordhavn
info@veloxis.com
www.veloxis.com
Income statement (kUSD)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 45 335.00 | ||||
| Other operating income | 1 212 467.00 | ||||
| Gross profit | 45 335.00 | ||||
| Costs of marketing | - 377.00 | - 214.00 | - 308.00 | - 589.00 | |
| Other operating expenses | -1 327.00 | -8.00 | |||
| EBIT | 1 256 475.00 | - 385.00 | - 214.00 | - 308.00 | - 589.00 |
| Other financial income | 2 604.00 | 90.00 | 52.00 | 36.00 | 67.00 |
| Interest income | 3 077.00 | ||||
| Other financial expenses | -1 385.00 | - 158.00 | -18.00 | -8.00 | - 335.00 |
| Pre-tax profit | 1 257 711.00 | 2 624.00 | - 180.00 | - 280.00 | - 857.00 |
| Income taxes | - 200 250.00 | - 564.00 | 77.00 | -12 989.00 | 213.00 |
| Net earnings | 1 057 461.00 | 2 060.00 | - 103.00 | -13 269.00 | - 644.00 |
Assets (kUSD)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible rights | 9.00 | ||||
| Intangible assets total | 9.00 | ||||
| Other tangible assets | 13.00 | ||||
| Tangible assets total | 13.00 | ||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 170.00 | 225.00 | 203.00 | 86 584.00 | |
| Current owed by particip. interest comp. | 1 300 017.00 | ||||
| Prepayments and accrued income | 182.00 | 162.00 | 145.00 | 124.00 | 101.00 |
| Current other receivables | 310.00 | - 162.00 | - 222.00 | - 124.00 | -86 370.00 |
| Current deferred tax assets | 64.00 | 77.00 | 86 269.00 | ||
| Short term receivables total | 1 300 573.00 | 170.00 | 225.00 | 203.00 | 86 584.00 |
| Cash and bank deposits | 3 546.00 | 3 715.00 | 3 142.00 | 3 123.00 | 3 332.00 |
| Cash and cash equivalents | 3 546.00 | 3 715.00 | 3 142.00 | 3 123.00 | 3 332.00 |
| Balance sheet total (assets) | 1 304 141.00 | 3 885.00 | 3 367.00 | 3 326.00 | 89 916.00 |
Equity and liabilities (kUSD)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 26 422.00 | 57.00 | 57.00 | 57.00 | 99 840.00 |
| Share premium account | 329 672.00 | ||||
| Retained earnings | - 109 640.00 | 764.00 | 2 824.00 | 2 721.00 | -10 548.00 |
| Profit of the financial year | 1 057 461.00 | 2 060.00 | - 103.00 | -13 269.00 | - 644.00 |
| Shareholders equity total | 1 303 915.00 | 2 881.00 | 2 778.00 | -10 491.00 | 88 648.00 |
| Non-current liabilities total | |||||
| Current owed to group member | 168.00 | 400.00 | 539.00 | 811.00 | 1 246.00 |
| Short-term deferred tax liabilities | 564.00 | 12 989.00 | |||
| Other non-interest bearing current liabilities | 58.00 | 40.00 | 50.00 | 17.00 | 23.00 |
| Current liabilities total | 226.00 | 1 004.00 | 589.00 | 13 817.00 | 1 269.00 |
| Balance sheet total (liabilities) | 1 304 141.00 | 3 885.00 | 3 367.00 | 3 326.00 | 89 917.00 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.